EE200300184A - Farmatseutiline kompositsioon, mis sisaldab kamptotetsiini kombinatsioonis stilbeeni derivaadiga, ning selle kasutamine vähktõve raviks - Google Patents

Farmatseutiline kompositsioon, mis sisaldab kamptotetsiini kombinatsioonis stilbeeni derivaadiga, ning selle kasutamine vähktõve raviks

Info

Publication number
EE200300184A
EE200300184A EEP200300184A EEP200300184A EE200300184A EE 200300184 A EE200300184 A EE 200300184A EE P200300184 A EEP200300184 A EE P200300184A EE P200300184 A EEP200300184 A EE P200300184A EE 200300184 A EE200300184 A EE 200300184A
Authority
EE
Estonia
Prior art keywords
camptothecin
cancer
treatment
combination
pharmaceutical composition
Prior art date
Application number
EEP200300184A
Other languages
English (en)
Inventor
Bissery Marie-Christine
Original Assignee
Aventis Pharma S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma S.A. filed Critical Aventis Pharma S.A.
Publication of EE200300184A publication Critical patent/EE200300184A/et

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
EEP200300184A 2000-10-27 2001-10-25 Farmatseutiline kompositsioon, mis sisaldab kamptotetsiini kombinatsioonis stilbeeni derivaadiga, ning selle kasutamine vähktõve raviks EE200300184A (et)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US24343100P 2000-10-27 2000-10-27
US24558200P 2000-11-06 2000-11-06
US25013800P 2000-12-01 2000-12-01
PCT/EP2001/012985 WO2002034244A2 (en) 2000-10-27 2001-10-25 A combination comprising camptothecin and a stilbene derivative for the treatment of cancer

Publications (1)

Publication Number Publication Date
EE200300184A true EE200300184A (et) 2003-08-15

Family

ID=27399663

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200300184A EE200300184A (et) 2000-10-27 2001-10-25 Farmatseutiline kompositsioon, mis sisaldab kamptotetsiini kombinatsioonis stilbeeni derivaadiga, ning selle kasutamine vähktõve raviks

Country Status (22)

Country Link
US (1) US6562834B2 (et)
EP (1) EP1333820A2 (et)
JP (1) JP2004517821A (et)
KR (1) KR100742524B1 (et)
CN (1) CN1200712C (et)
AU (2) AU1602902A (et)
BG (1) BG107806A (et)
BR (1) BR0114856A (et)
CA (1) CA2426898A1 (et)
EA (1) EA005400B1 (et)
EE (1) EE200300184A (et)
HK (1) HK1058623A1 (et)
HR (1) HRP20030382A2 (et)
HU (1) HUP0302629A3 (et)
IL (1) IL155509A0 (et)
MX (1) MXPA03002882A (et)
NO (1) NO324844B1 (et)
NZ (1) NZ524855A (et)
PL (1) PL365685A1 (et)
SK (1) SK5122003A3 (et)
WO (1) WO2002034244A2 (et)
YU (1) YU29803A (et)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020183266A1 (en) * 2001-03-15 2002-12-05 Aventis Pharma, S.A. Combination comprising combretastatin and anticancer agents
US7850990B2 (en) * 2001-10-03 2010-12-14 Celator Pharmaceuticals, Inc. Compositions for delivery of drug combinations
CA2383259A1 (en) * 2002-04-23 2003-10-23 Celator Technologies Inc. Synergistic compositions
US20080075762A1 (en) * 2001-10-03 2008-03-27 Paul Tardi Compositions for delivery of drug combinations
TW200819409A (en) 2006-10-19 2008-05-01 Univ Taipei Medical Z-stilbenes derivatives and the pharmaceutical composition thereof
CA2826034A1 (en) 2011-01-28 2012-08-02 University Of Kentucky Research Foundation Stilbene analogs and methods of treating cancer
AU2012275841A1 (en) 2011-06-27 2014-01-16 The Jackson Laboratory Methods and compositions for treatment of cancer and autoimmune disease

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4399276A (en) 1981-01-09 1983-08-16 Kabushiki Kaisha Yakult Honsha 7-Substituted camptothecin derivatives
JPS57116015A (en) 1981-01-09 1982-07-19 Yakult Honsha Co Ltd Antitumor agent
JPS57116074A (en) 1981-01-09 1982-07-19 Yakult Honsha Co Ltd Novel camptothecin derivative and its preparation
US4473692A (en) 1981-09-04 1984-09-25 Kabushiki Kaisha Yakult Honsha Camptothecin derivatives and process for preparing same
JPS58154582A (ja) 1982-03-10 1983-09-14 Yakult Honsha Co Ltd 新規なカンプトテシン誘導体およびその製造法
JPS595188A (ja) 1982-06-30 1984-01-12 Yakult Honsha Co Ltd １０−ヒドロキシカンプトテシンの製造法
JPS6019790A (ja) 1983-07-14 1985-01-31 Yakult Honsha Co Ltd 新規なカンプトテシン誘導体
US4981968A (en) 1987-03-31 1991-01-01 Research Triangle Institute Synthesis of camptothecin and analogs thereof
CA1332413C (en) 1987-06-25 1994-10-11 Kabushiki Kaisha Yakult Honsha Camptothecin derivatives and process for preparing same
US5004758A (en) 1987-12-01 1991-04-02 Smithkline Beecham Corporation Water soluble camptothecin analogs useful for inhibiting the growth of animal tumor cells
JPH0615547B2 (ja) 1988-01-20 1994-03-02 株式会社ヤクルト本社 新規なカンプトテシン誘導体
JP2524804B2 (ja) 1988-03-29 1996-08-14 株式会社ヤクルト本社 新規なカンプトテシン誘導体及びその製造法
JP2524803B2 (ja) 1988-03-29 1996-08-14 株式会社ヤクルト本社 新規なカンプトテシン誘導体およびその製造法
EP0540099B1 (en) 1991-10-29 1996-04-17 Glaxo Wellcome Inc. Water soluble camptothecin derivatives
TW325458B (en) * 1993-09-08 1998-01-21 Ajinomoto Kk Stilbene derivatives and pharmaceutical compositions comprising the same for anti-cancer
TW334418B (en) 1995-03-07 1998-06-21 Ajinomoto Kk Stilbene derivatives and pharmaceutical compositions
US6504029B1 (en) 1995-04-10 2003-01-07 Daiichi Pharmaceutical Co., Ltd. Condensed-hexacyclic compounds and a process therefor
GB9510716D0 (en) 1995-05-26 1995-07-19 Pharmacia Spa Substituted camptothecin derivatives and process for their preparation
US5663177A (en) 1995-05-31 1997-09-02 Smithkline Beecham Corporation Water soluble camptothecin analogs
US5670500A (en) 1995-05-31 1997-09-23 Smithkline Beecham Corporation Water soluble camptothecin analogs
PT835258E (pt) 1995-06-21 2003-02-28 Sod Conseils Rech Applic Novos analogos de camptotecina, processos para a sua preparacao, sua utilizacao como farmacos e composicoes farmaceuticas que os contem
JP3054669B2 (ja) 1995-10-16 2000-06-19 余川商事株式会社 積雪落下防止装置
JPH11296051A (ja) 1998-04-08 1999-10-29 Canon Inc プロセスカートリッジ
DE69942128D1 (de) * 1998-12-11 2010-04-22 Coulter Pharm Inc Prodrugs und verfahren zu deren herstellung
GB9903404D0 (en) * 1999-02-16 1999-04-07 Angiogene Pharm Ltd Methods of treatment and compositions useful for the treatment of diseases involving angiogenesis
CA2432792C (en) 2000-12-22 2012-04-03 Bristol-Myers Squibb Company Methods for modulating tumor growth and metastasis

Also Published As

Publication number Publication date
JP2004517821A (ja) 2004-06-17
KR20030082544A (ko) 2003-10-22
NO20031656L (no) 2003-04-10
BG107806A (bg) 2004-06-30
IL155509A0 (en) 2003-11-23
HUP0302629A2 (hu) 2003-11-28
AU2002216029B2 (en) 2006-01-05
US20020115677A1 (en) 2002-08-22
HK1058623A1 (en) 2004-05-28
US6562834B2 (en) 2003-05-13
HUP0302629A3 (en) 2005-05-30
PL365685A1 (en) 2005-01-10
CN1471396A (zh) 2004-01-28
NO20031656D0 (no) 2003-04-10
EA200300516A1 (ru) 2003-08-28
NO324844B1 (no) 2007-12-17
HRP20030382A2 (en) 2005-04-30
WO2002034244A2 (en) 2002-05-02
MXPA03002882A (es) 2004-12-03
SK5122003A3 (en) 2003-12-02
BR0114856A (pt) 2004-06-15
KR100742524B1 (ko) 2007-08-02
NZ524855A (en) 2004-10-29
AU1602902A (en) 2002-05-06
EA005400B1 (ru) 2005-02-24
WO2002034244A3 (en) 2003-05-30
CA2426898A1 (en) 2002-05-02
CN1200712C (zh) 2005-05-11
YU29803A (sh) 2006-05-25
EP1333820A2 (en) 2003-08-13

Similar Documents

Publication Publication Date Title
EE200300145A (et) Asa- ja polüasanaftalenüülkarboksamiidid ja farmatseutiline kompositsioon
EE200200484A (et) Väikeseannuseline entekaviiripreparaat ja selle kasutamine
EE04852B1 (et) C-21 modifitseeritud epotioloonid, nende valmistamise meetod ning kasutamine ja ravimkoostise kasutamine vähkkasvajate või teiste proliferatiivsete haiguste ravimisel
EE200300544A (et) 4-anilinokinoliin-3-karboksamiidid, nende kasutamine ning valmistamine
ATE478840T1 (de) 3-aminoazetidinderivate enthaltende pharmazeutische zusammensetzungen, diese derivate und deren herstellung
EE200300151A (et) Ravimitena kasutatavad antikolinergikumid ning meetodid nende valmistamiseks
PT1313489E (pt) Composicoes farmaceuticas para o tratamento de mucosite, estomatite e sindroma de behcet
DE60211532D1 (de) Pastöse zusammensetzung und diese enthaltende kosmetika
HUP0302943A3 (en) New heterocyclic compounds, preparation thereof and use as medicines, in particular as antibacterial agents
AR027968A1 (es) Una composicion para utilizar en el tratamiento y/o prevencion del sarampion y el uso de dicha composicion para un vehiculo para el tratamiento o prevencion del sarampion
AR028296A1 (es) Metodos sinergisticos y composiciones para el tratamiento del cancer
ATE306920T1 (de) Kondensierte pyrrolocarbazole gegen entzündungen
IS8349A (is) 2,4-pýrimídíndíamín gagnleg í meðhöndlun æxlissjúkdóma, bólgu- og ónæmiskerfissjúkdóma
ATE468324T1 (de) Pharmazeutische zusammensetzung
AR028622A1 (es) Derivados de tropano utiles en terapia
EE05306B1 (et) Arlitud furaan- ja tiofeenkarboksamiid, seda sisaldav ravimpreparaat ning hendi kasutamine kaaliumikanali blokaatorina toimiva ravimi valmistamiseks
AR027945A1 (es) Uso de pramipexol en el tratamiento de transtornos de adiccion
DE60118008D1 (de) Pharmazeutische zusammensetzungen mit amlodipinmaleat
EE04490B1 (et) Ühend, selle valmistamise meetod ning kasutamine meditsiinis
EE05003B1 (et) Dihdro-1,3,5-triasiinamino derivaadid ja nende kasutamine ravis
EE200200471A (et) Farmatseutiline kompositsioon, mis sisaldab kamptotetsiini või selle derivaati kombinatsioonis pürimidiini derivaadiga ning on ette nähtud vähktõve raviks
DE60305037D1 (de) Piperazinylacylpiperidinderivate, deren herstellung und deren therapeutische anwendung
AU2001283285A1 (en) Antimicrobial composition and methods of use in the treatment of disease
PT1228028E (pt) Sais de hidroxieicosatetraeniato, composicoes e metodos para utilizacao no tratamento de perturbacoes da secura ocular
ITMI20000249A0 (it) Citochine modificate per uso nella terapia del cancro